Patient info Open main menu

Metrogel 0.75% w/w Gel – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
7.5 mg/gram
Contains active substance:
Similar medicines:

Patient leaflet - Metrogel

1. What Metrogel is and what it is used for

  • Your doctor has prescribed this gel for your skin condition, rosacea.
  • It helps to treat the pimples, pustules (spots) and redness found with this condition.
  • Metrogel contains the active substance metronidazole. Metronidazole belongs to a group of medicines called antiprotozoal and antibacterial agents and has been shown to help to control infection and inflammation in certain skin problems, such as rosacea.

2. What you need to know before you use Metrogel

Do not use Metrogel

  • If you are allergic to metronidazole or any of the other ingredients of this medicine (listed in section 6). An allergic reaction may include a rash or itching.

Warnings and precautions

Talk to your doctor or pharmacist before using Metrogel.

  • Do not get the gel in your eyes. If you do, rinse thoroughly with large amounts of warm water or eye wash.
  • If you suffer from any blood disorders do not use Metrogel unless your doctor says you can.
  • This product should not be used in children.
  • Do not go out into strong sunlight (including sun-bathing) and avoid exposure to ultra-violet light (eg solariums, sun-lamps) while you are using this product.
  • Avoid prolonged and unnecessary use of this medicine.

Other medicines and Metrogel

Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.

  • Using Metrogel could interfere with drugs used to reduce blood clotting (anticoagulants) such as warfarin and dicoumarin. Contact your doctor for advice if you are taking medicines to reduce blood clotting, or if you suffer from any other blood disorders. Metrogel with alcohol

Metronidazole taken by mouth can react with alcohol. This reaction is unlikely with Metrogel because it is only applied on the skin. However, you are advised not to drink alcohol while you are using Metrogel.

Pregnancy and breast-feeding

  • If you are pregnant or breast-feeding, it may not be advisable to use this product, unless your doctor considers it essential. If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Metrogel contains

  • 50mg propylene glycol (E1520) in each gram which is equivalent to 5% w/w, it may cause skin irritation.
  • hydroxybenzoic acid esters which may cause allergic reactions (possibly delayed).
  • bronopol which may cause local skin reactions (e.g contact dermatitis).

NOTICE RECTO VERSO 147 x 208 PLAN n°09.DRA.2251.R00.2

Product code: P24926-5

Product description: METROGEL BIOGLAN Market: GBR

Article: Leaflet

Flat size: 147x208

GRAPHIC DESIGNER: Guillaume ANDRÉ INDUSTRIALIZATION DEPARTMENT

LABORATOIRES GALDERMA - Z.I. Galderma - 74540 ALBY-SUR-CHÉRAN - FRANCE

DIELINES

3. How to use Metrogel

Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

  • First wash and dry the affected areas of your skin.
  • Apply a thin layer of the gel to all the affected areas - be careful not to get it in your eyes.
  • Rub the gel in well.
  • Always replace the cap and wash your hands after use.
  • Your gel should be used in this way twice a day, (morning and evening), or as advised by your doctor.
  • Your doctor will decide how long you need to use Metrogel to keep your rosacea under control. If you use more Metrogel than you should or accidentally swallow the gel
  • This product is for use on the skin only. Do not swallow it. If you accidentally do so, seek medical advice. If you forget to use Metrogel
  • Although this gel works best if you use it regularly as directed, don’t worry if you forget to use your gel at the right time. When you do remember, start using it again in the same way as before.

If you stop taking Metrogel

Rosacea may respond slowly to antibiotics. It is important that you continue using Metrogel until your doctor tells you to stop. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them

Common: may affect up to 1 in 10 people

  • dry skin
  • redness of the skin (erythema)
  • itching of the skin (pruritus)
  • skin discomfort (burning, pain of skin / stinging)
  • skin irritation
  • worsening of rosacea

Uncommon: may affect up to 1 in 100 people

  • numbness (hypothesia) and tingling (paraesthesia) in the fingers or toes
  • metallic taste (dysgeusia)
  • feeling sick (nausea)

Not known: frequency cannot be estimated from the available data

  • contact dermatitis
  • swelling of the face
  • peeling skin (exfoliation)

If skin irritation should occur either use the gel a little less often or even stop using it until the irritation settles down. Seek medical advice from your doctor or pharmacist if necessary.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Metrogel

  • Keep this medicine out of the sight and reach of children.
  • Do not use this medicine after the expiry date which is stated on the tube and carton.
  • Store between 15°C- 25°C. Store in the original tube.
  • Do not refrigerate.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Metrogel contains

The active substance is metronidazole. Each gram of Metrogel contains 7.5mg of metronidazole. The other ingredients are phosphoric acid, hydroxybenzoic acid esters, bronopol, hydroxyethyl cellulose, propylene glycol (E1520) and purified water. What Metrogel looks like and contents of the pack

  • Metrogel is a clear gel.
  • Metrogel is available in 25 g and 40 g tubes. Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder: Galderma (U.K.) Limited, Evergreen House North, Grafton Place, London, England, NW1 2DX. (PL 10590/0035)

Manufacturer: Bioglan AB, PO Box 50310, S-202 13 Malmö, Sweden.

This leaflet was last revised in February 2022.

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 10590/0035

Last revision stated in the text: February 2022 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Metrogel

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Metronidazole
Strength 7.5 mg/gram
Pharmaceutical form Cutaneous gel
How is it taken Cutaneous
Excipients Bronopol BP,, Hydroxybenzoic acid esters,, Hydroxyethylcellulose,, Propylene glycol (E1520),, Phosphoric acid,, Purified water.
Pack sizes 40 gram
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 2 years.
Storage Store between 15°C and 25°C in a dry place.
Drug group (ATC) Chemotherapeutics for external use
  1. D Dermatologicals
    1. D06 Antibiotics and chemotherapeutics for dermatological use
      1. D06B Chemotherapeutics for topical use
        1. D06BX Other chemotherapeutics
          1. D06BX01 metronidazole
Marketing authorisation PL 10590/0035 (first authorised 27 February 1998)
Marketing authorisation holder Galderma (U.K.) Limited
Codes GTIN 5020465200109 · BNF 13100102

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.